Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 18/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8587602 | 0.77 | ACACB (0.47) | FFAR1FFAR4ACACB | |
| SCHEMBL22011122 | 0.75 | MAPT (0.32) | FFAR1FFAR4 | |
| SCHEMBL18310400 | 0.74 | FFAR1 (0.47) | FFAR1FFAR4ACACB | |
| SCHEMBL7859826 | 0.73 | FFAR1 (0.55) | FFAR1FFAR4ACACB | |
| SCHEMBL7858585 | 0.70 | FFAR1 (0.52) | FFAR1FFAR4ACACB | |
| SCHEMBL7858754 | 0.70 | FFAR1 (0.52) | FFAR1FFAR4ACACB | |
| SCHEMBL9355338 | 0.70 | FFAR1 (0.42) | FFAR1FFAR4 | |
| SCHEMBL7859016 | 0.70 | FFAR1 (0.47) | FFAR1FFAR4ACACB | |
| SCHEMBL10302794 | 0.70 | FFAR4 (0.40) | FFAR1FFAR4ACACBCYP11B1CYP11B2 | |
| SCHEMBL7861607 | 0.69 | FFAR1 (0.51) | FFAR1FFAR4ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | FFAR1 193/4885FFAR4 254/4885ACACB 2290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.